Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
The Health Risks and Benefits of Weight-Loss Drugs
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight. In report published in Nature Medicine,
GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditions
The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an assessment of how the drugs affect 175 conditions
Popular weight loss drugs could be cheaper for some Americans: What you need to know
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as cancer, asthma, type 2 diabetes and weight loss - Ozempic, Rybelsus and Wegovy. Austedo and Austedo XR, used to treat Huntington’s disease.
Taking Ozempic for weight loss? You might find other benefits, too - and a few risks
A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks
Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for weight management. The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists,
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.
Major study of weight-loss jabs shows slew of benefits but also risks
The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.
5h
Philippines to 'respond favourably' if ICC seeks Interpol arrest warrants over drugs crackdown
The Philippines will respond favourably if Interpol is asked by the International Criminal Court to issue arrest warrants ...
21h
How breakthroughs in AI are helping to design life-saving drugs faster than ever before
A team of scientists at the University of Toronto have successfully implemented AI tools to speed up the process of ...
2d
on MSN
Trump signs death penalty order directing attorney general to help states get lethal injection drugs
President Donald Trump has signed a sweeping execution order on the death penalty that directs the attorney general to “take ...
Medical News Today
2d
GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
KOLR Springfield on MSN
2d
Upstate law enforcement seize over 30 pounds of drugs in one day
GREENWOOD, S.C. (WSPA) – More than 30 pounds of drugs were confiscated in a single action by Greenwood Police Department last ...
1d
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
“Improving prescription drug affordability for Medicare enrollees is the core of the Inflation Reduction Act, and the next ...
WPEC West Palm Beach on MSN
1d
Bag labeled 'Definitely Not A Bag Full Of Drugs' found full of drugs in Central Florida
A Florida woman was arrested for the second time in less than two weeks after deputies discovered drugs in a bag labeled ...
Moneyweb
7m
The appetite for GLP-1 drugs grows
The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, ...
1d
on MSN
FDA warns of serious allergic reactions with some multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback